United Therapeutics Corporation Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount
United Therapeutics Corporation (UTHR) reported Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount of $6.30 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-25.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationNondeductibleExpenseOther · last filed 2026-02-25
- United Therapeutics Corporation effective income tax rate reconciliation, nondeductible expense, other, amount for fiscal 2025 was $6.30M, a 53.66% increase from fiscal 2024.
- United Therapeutics Corporation effective income tax rate reconciliation, nondeductible expense, other, amount for fiscal 2024 was $4.10M, a 70.71% decline from fiscal 2023.
- United Therapeutics Corporation effective income tax rate reconciliation, nondeductible expense, other, amount for fiscal 2023 was $14.00M.
- United Therapeutics Corporation effective income tax rate reconciliation, nondeductible expense, other, amount for fiscal 2022 was $0.00.
| Period end | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount 12 month | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount 12 month as first filed |
|---|---|---|
| 2025-12-31 | $6.30M 10-K · filed 2026-02-25 | |
| 2024-12-31 | $4.10M 10-K · filed 2026-02-25 | $0.00 10-K · filed 2025-02-26 |
| 2023-12-31 | $14.00M 10-K · filed 2026-02-25 | $9.10M 10-K · filed 2024-02-21 |
| 2022-12-31 | $0.00 10-K · filed 2025-02-26 | |
| 2021-12-31 | $0.00 10-K · filed 2024-02-21 | |
| 2017-12-31 | $19.00M 10-K · filed 2020-02-26 | |
| 2016-12-31 | $2.20M 10-K · filed 2017-02-22 | |
| 2015-12-31 | -$2.00M 10-K · filed 2017-02-22 | |
| 2014-12-31 | -$700.00K 10-K · filed 2017-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |